Aanem Presents Nerve And Muscle Junction
Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis (MG), Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 1:06:51
- Mas informaciones
Informações:
Sinopsis
Elie Naddaf, MD, interviews James Howard, MD, about the use of complement and the neonatal Fc receptor inhibitors in myasthenia gravis (MG), highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials.
